← back to search

Paula Munderi

London School of Hygiene & Tropical Medicine · GB
Area of research
Infectious Diseases · Virology
Research interest
Research interests include Medicine, Internal medicine, Regimen, Placebo, Malaria, and Incidence (geometry).
h-index
citations
1,104
works
20
NIH funding
primary concept
email

Recent publications

Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda
Journal of Clinical Hypertension 2019cited by 49position: middledoi
Dyslipidemias and cardiovascular risk scores in urban and rural populations in north-western Tanzania and southern Uganda
PLoS ONE 2019cited by 12position: middledoi
Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy
The Journal of Infectious Diseases 2019cited by 9position: middledoi
Expert consensus statement on the science of <scp>HIV</scp> in the context of criminal law
Journal of the International AIDS Society 2018cited by 112position: middledoi
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
PLoS ONE 2018cited by 23position: lastdoi
Improving antiretroviral therapy adherence in resource‐limited settings at scale: a discussion of interventions and recommendations
Journal of the International AIDS Society 2017cited by 195position: middledoi
Cardiometabolic risk among hiv-positive Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy
Pan African Medical Journal 2017cited by 56position: lastdoi
COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort
AIDS Research and Therapy 2017cited by 26position: lastdoi
The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis
AIDS Research and Therapy 2016cited by 16position: lastdoi
Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
AIDS 2016cited by 13position: middledoi
From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
BMC Research Notes 2016cited by 11position: lastdoi
Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda
Contemporary Clinical Trials Communications 2016cited by 5position: middledoi
Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
Malaria Journal 2016cited by 3position: middledoi
High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda
BMC Medicine 2015cited by 211position: middledoi
Readiness of Ugandan health services for the management of outpatients with chronic diseases
Tropical Medicine & International Health 2015cited by 153position: middledoi
Towards host-directed therapies for tuberculosis
Nature Reviews Drug Discovery 2015cited by 129position: middledoi
The health system burden of chronic disease care: an estimation of provider costs of selected chronic diseases in Uganda
Tropical Medicine & International Health 2015cited by 40position: middledoi
Effect of cotrimoxazole prophylaxis on malaria occurrence in <scp>HIV</scp>‐infected patients on antiretroviral therapy in sub‐Saharan Africa
Tropical Medicine & International Health 2015cited by 15position: middledoi
Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy
AIDS 2015cited by 13position: middledoi
Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
Contemporary Clinical Trials 2015cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Heiner Grosskurth · London School of Hygiene & Tropical Medicine13 papers (2015–2019)Jonathan Levin · University of York8 papers (2015–2019)Kathy Baisley · London School of Hygiene & Tropical Medicine7 papers (2015–2019)Ronnie Kasirye · London School of Hygiene & Tropical Medicine7 papers (2015–2018)Zacchaeus Anywaine · London School of Hygiene & Tropical Medicine7 papers (2015–2019)Andrew Nunn · London School of Hygiene & Tropical Medicine6 papers (2015–2018)Pontiano Kaleebu · Uganda Virus Research Institute5 papers (2016–2019)Anatoli Kamali · London School of Hygiene & Tropical Medicine5 papers (2015–2016)David Katende · London School of Hygiene & Tropical Medicine4 papers (2015–2019) · 4 papers (2016–2017)Ivan Kasamba · London School of Hygiene & Tropical Medicine4 papers (2016–2017)Samuel Biraro · London School of Hygiene & Tropical Medicine4 papers (2015–2019) · 4 papers (2015–2019)Billy N. Mayanja · University of Cape Town4 papers (2016–2017) · 3 papers (2015–2019)Saidi Kapiga · London School of Hygiene & Tropical Medicine3 papers (2015–2019)Liam Smeeth · Qatar University3 papers (2015–2019)Joseph Lutaakome · Uganda Virus Research Institute3 papers (2016–2018)Robert N. Peck · Cornell University3 papers (2015–2019)Ivan Namakoola · Liverpool School of Tropical Medicine3 papers (2016–2017)